United States

Complete guide to Physician Payments Sunshine Act compliance for medical device manufacturers — covered recipients, reportable payment categories, 2026 thresholds, CMS submission process, state-level requirements, penalties, and audit preparation.

U.S. Agent and Official Correspondent fees run $1,000–$5,000+/year on top of FDA's $11,423 annual establishment fee. A buyer-side breakdown of hourly, registration-fee-plus-annual, and flat all-inclusive pricing models — with 3-year cash flow scenarios for foreign manufacturers selling into the United States in 2026.

Complete guide to translating Voice of the Customer (VOC) and user needs into verifiable design inputs for medical devices — 21 CFR 820.30, FDA QMSR, ISO 13485, traceability matrix examples, and best practices for building audit-ready documentation.

The complete go-to-market playbook for medical devices — regulatory-commercial alignment, hospital procurement, value analysis committees, sales channel models, pricing strategy, and the 18-month launch timeline from clearance to adoption.

Everything medical device manufacturers need to know about product liability — strict liability vs negligence, insurance coverage types, EU Directive 2024/2853 changes, recall coverage, and risk mitigation strategies for 2026 and beyond.

How cloud-based medical devices and SaaS health platforms are regulated in the US and EU — FDA and EU MDR classification of cloud-connected devices, SaMD vs SiMD distinction for cloud software, IEC 62304 Edition 2 lifecycle requirements, cybersecurity (SPDF, SBOM, IEC 81001-5-1), FDA CSA guidance for QMS cloud tools, EU Cyber Resilience Act impact, data integrity and validation challenges, and practical compliance strategies for manufacturers.

Complete guide to HIPAA compliance for medical device manufacturers — when HIPAA applies to devices, the 2026 Security Rule NPRM changes (mandatory encryption, MFA, network segmentation, 24-hour incident notification), business associate agreements for IoMT, FDA cybersecurity overlap, risk assessment frameworks, and step-by-step compliance strategies for connected medical devices.

Complete regulatory guide to mobile medical apps in 2026 — FDA Policy for Device Software Functions, when mobile apps are regulated as medical devices vs wellness products, the 2026 General Wellness and CDS guidance updates, EU MDR classification under Rule 11, mobile-specific cybersecurity and privacy requirements, app store compliance, and step-by-step classification strategies for mobile health developers.

How to perform bacterial endotoxin testing (BET) for medical devices — LAL gel-clot, chromogenic, and turbidimetric methods, recombinant Factor C (rFC), USP <85>/<161>, ISO 11737-3, FDA 2026 pyrogen guidance update, endotoxin limits by device type, method selection, and regulatory submissions.

How wearable medical devices are regulated in the US and EU — FDA 2026 general wellness guidance, wellness vs. medical device classification, 510(k) and De Novo pathways for smartwatches and CGMs, EU MDR classification, market size data, key cleared devices, and compliance strategy for manufacturers.

Master batch manufacturing records (BMR), electronic batch records (EBR), and device history records (DHR) for medical device manufacturing. Covers 21 CFR 210/211, 21 CFR Part 820/QMSR, ISO 13485, paper vs electronic systems, review workflows, deviation management, and FDA inspection readiness.

How to perform bioburden testing for medical devices under ISO 11737-1:2018 — method validation, recovery efficiency, extraction techniques, enumeration methods, dose setting, and routine monitoring for sterilization validation.

How to classify, design, validate, and monitor cleanrooms for medical device manufacturing under ISO 14644 — particle count limits, classification methodology, environmental monitoring programs, FDA and EU GMP requirements, and the 2025 update to ISO 14644-5.

How to calculate and reduce Cost of Quality in medical device manufacturing using the four-category model. Includes the 1-10-100 rule, McKinsey industry benchmarks (6.8–9.4% of sales), eQMS ROI data, and step-by-step implementation aligned with ISO 13485 and FDA QMSR.

How to transition from Computer System Validation (CSV) to Computer Software Assurance (CSA) under FDA's September 2025 final guidance — risk-based approach, testing strategies, documentation requirements, and step-by-step implementation roadmap.

Comprehensive guide to the FDA Emergency Use Authorization (EUA) pathway for medical devices under Section 564 of the FD&C Act — legal basis, CBRN emergency triggers, statutory criteria, submission process, EUA vs 510(k)/PMA comparison, post-COVID transition framework, and current active EUAs.

How to manage Engineering Change Orders (ECOs) in medical device manufacturing — ECR to ECO to ECN workflow, ISO 13485 Clause 7.3.9 requirements, FDA QMSR design change control, risk assessment, regulatory notification triggers, and best practices for cross-functional approval.

How to build and manage an equipment calibration program for medical device manufacturing — ISO 13485 Clause 7.6 requirements, FDA QMSR compliance, NIST traceability, ISO 17025 accreditation, calibration schedules, out-of-tolerance procedures, and electronic calibration management.

Complete guide to FDA medical device advertising and promotion regulations — 21 CFR Part 801 labeling requirements, OPEQ enforcement, off-label promotion rules, social media compliance, FTC oversight, warning letters, and practical strategies for compliant promotional claims.

Complete guide to FDA's January 2026 Clinical Decision Support software guidance — the four statutory criteria for non-device CDS exclusion under Section 520(o)(1)(E), device vs non-device examples, SaMD boundary decisions, enforcement discretion positions, and practical compliance strategies for digital health companies.